Related references
Note: Only part of the references are listed.The derived neutrophil to lymphocyte ratio is an independent prognostic factor in patients with diffuse large B-cell lymphoma
K. Troppan et al.
BRITISH JOURNAL OF CANCER (2014)
Neutrophil-lymphocyte ratio as a predictor of outcomes for patients with hepatocellular carcinoma undergoing TAE combined with Sorafenib
Kai Wei et al.
MEDICAL ONCOLOGY (2014)
Preoperative Neutrophil-to-Lymphocyte Ratio Is a Predictor of Survival After Hepatectomy for Hepatocellular Carcinoma A Retrospective Analysis
Yohei Mano et al.
ANNALS OF SURGERY (2013)
The effects of hematological parameters and tumor-infiltrating lymphocytes on prognosis in patients with gastric cancer
Ahmet Dirican et al.
CANCER BIOMARKERS (2013)
Neutrophil-lymphocyte ratio predicts overall and recurrence-free survival after liver transplantation for hepatocellular carcinoma
Alpna R. Limaye et al.
HEPATOLOGY RESEARCH (2013)
External Validation of the Derived Neutrophil to Lymphocyte Ratio as a Prognostic Marker on a Large Cohort of Pancreatic Cancer Patients
Joanna Szkandera et al.
PLOS ONE (2013)
Prognostic Factors Affecting Survival at Recurrence of Hepatocellular Carcinoma After Living-Donor Liver Transplantation: With Special Reference to Neutrophil/Lymphocyte Ratio
Norifumi Harimoto et al.
TRANSPLANTATION (2013)
Usefulness of the Neutrophil-to-Lymphocyte Ratio in Predicting Short- and Long-Term Mortality in Breast Cancer Patients
Basem Azab et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinoma
A. Kinoshita et al.
BRITISH JOURNAL OF CANCER (2012)
A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI)
D. J. Pinato et al.
BRITISH JOURNAL OF CANCER (2012)
A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer
M. J. Proctor et al.
BRITISH JOURNAL OF CANCER (2012)
Cancers with increasing incidence trends in the United States: 1999 through 2008
Edgar P. Simard et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Prognostic value of pre-treatment circulating monocyte count in patients with cervical cancer: Comparison with SCC-Ag level
Yoo-Young Lee et al.
GYNECOLOGIC ONCOLOGY (2012)
Pre-treatment diagnosis of endometrial cancer through a combination of CA125 and multiplication of neutrophil and monocyte
Bo Wook Kim et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2012)
The Activation Pattern of Blood Leukocytes in Head and Neck Squamous Cell Carcinoma Is Correlated to Survival
Camilla Rydberg Millrud et al.
PLOS ONE (2012)
Elevated Preoperative Neutrophil:Lymphocyte Ratio as a Predictor of Postoperative Disease Recurrence in Esophageal Cancer
Reem Z. Sharaiha et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Use of Inflammatory Markers to Guide Cancer Treatment
S. J. Clarke et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Usefulness of a Modified Inflammation-Based Prognostic System for Predicting Postoperative Mortality of Patients Undergoing Surgery for Primary Hepatocellular Carcinoma
Mitsuru Ishizuka et al.
JOURNAL OF SURGICAL ONCOLOGY (2011)
The predictive value of pre-treatment inflammatory markers in advanced non-small-cell lung cancer
G. Kasymjanova et al.
Current Oncology (2010)
High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer
Hideaki Shimada et al.
GASTRIC CANCER (2010)
Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma
Richard A. Smith et al.
AMERICAN JOURNAL OF SURGERY (2009)
Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment
HanByoul Cho et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
Francesco Colotta et al.
CARCINOGENESIS (2009)
Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer
Khaled M. Sarraf et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2009)
Peripheral blood neutrophils as independent immunologic predictor of response and long-term survival upon immunotherapy in metastatic renal-cell carcinoma
Jens Atzpodien et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2008)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer
E. F. Leitch et al.
BRITISH JOURNAL OF CANCER (2007)
Prognostic value of preoperative peripheral blood monocyte count in patients with hepatocellular carcinoma
Atsushi Sasaki et al.
SURGERY (2006)
Management of hepatoceullular carcinoma
J Bruix et al.
HEPATOLOGY (2005)
Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer
SR Walsh et al.
JOURNAL OF SURGICAL ONCOLOGY (2005)
A prospective longitudinal study of performance status, an inflammation-based score (GPS) and survival in patients with inoperable non-small-cell lung cancer
LM Forrest et al.
BRITISH JOURNAL OF CANCER (2005)
The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma
K Hashimoto et al.
CANCER (2005)
The immunobiology of cancer immunosurveillance and immunoediting
GP Dunn et al.
IMMUNITY (2004)
Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: A population-based study
JA Davila et al.
GASTROENTEROLOGY (2004)
Estimating the world cancer burden: GLOBOCAN 2000
DM Parkin et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Share Paper
